Transcriptional profiling refines DLBCL classification and identifies subtypes with distinct therapeutic vulnerabilities
Year: 2025
Type: conference-abstract
Source: Blood
Institutions: City Of Hope National Medical Center, City of Hope, Weill Cornell Medicine, Yale University, Memorial Sloan Kettering Cancer Center, Charles University, University of Münster, University Hospital Münster, Centre Hospitalier Universitaire de Lille, Centre Henri Becquerel, University of Chicago
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417016714
